Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 13 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 10202618

    Method of treating type I diabetes using an AAV vector encoding uracortin 2

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  2. US 10202595

    Chimeric clotting factors

    BIOVERATIV THERAPEUTICS INC. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  3. US 10201597

    Codon-optimized lentiviral vector for stem cell reprogramming

    The Regents of the University of California · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  4. US 10179112

    Viral vector nanocapsule for targeting gene therapy and its preparation

    The Regents of the University of California · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  5. US 10179919

    Multigenome retroviral vector preparations and methods and systems for producing and using same

    IMMUNE DESIGN CORP. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  6. US 10172932

    Ebola virus disease vaccine taking human replication deficient adenovirus as vector

    Institute of Biotechnology, Academy of Military Medical Sciences, China · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  7. US 10160961

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  8. US 10155796

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  9. US 10143760

    Liver-specific constructs, factor VIII expression cassettes and methods of use thereof

    Sangamo Therapeutics, Inc. · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  10. US 10138291

    Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  11. US 10113151

    Composition of viral vectors in lecithin liposomes, preparation method and treatment methods

    The Regents of the University of California · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  12. US 10113183

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  13. US 10111859

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  14. US 10081668

    Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  15. US 10081659

    Adeno-associated vectors for enhanced transduction and reduced immunogenicity

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  16. US 10052362

    Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

    The United States Geovernment represented by the United States Department of Veterans Affairs · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  17. US 10046010

    Methods of generating mesenchymal stem cells which secrete neurotrophic factors

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  18. US 10035833

    Vascular endothelial growth factor antagonists and methods of making

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  19. US 10023628

    Cell line expressing single chain factor VIII polypeptides and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  20. US 10023627

    Vascular endothelial growth factor fusion protein

    KOREA PRIME PHARM CO., LTD. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  21. US 10010622

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  22. US 10005838

    Milk fat globule epidermal growth factor 8 regulates fatty acid uptake

    The Regents of the University of California · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  23. US 10004775

    Inhibition of hypoxia-inducible factor activity with carica papaya extracts

    The Regents of the University of California · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  24. US 10001495

    Blood factor monitoring assay and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.